enrofloxacin has been researched along with Otitis Externa in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Bae, S; Oh, T; Park, S | 1 |
| Chan, WY; Hickey, EE; Hill, PB; Page, SW; Trott, DJ | 1 |
| Cole, LK; Hillier, A; Kwochka, KW; Lehman, AM; Papich, MG; Smeak, DD | 1 |
| Brothers, AM; Gibbs, PS; Wooley, RE | 1 |
| Cole, LK; Hillier, A; Kelbick, NT; Kowalski, JJ; Kwochka, KW; Smeak, DD | 1 |
| Nuttall, T | 1 |
2 trial(s) available for enrofloxacin and Otitis Externa
| Article | Year |
|---|---|
Plasma and ear tissue concentrations of enrofloxacin and its metabolite ciprofloxacin in dogs with chronic end-stage otitis externa after intravenous administration of enrofloxacin.
Topics: Animals; Anti-Bacterial Agents; Chronic Disease; Ciprofloxacin; Dog Diseases; Dogs; Dose-Response Relationship, Drug; Ear Canal; Enrofloxacin; Female; Fluoroquinolones; Injections, Intravenous; Male; Otitis Externa; Skin; Tissue Distribution | 2009 |
Ciprofloxacin as a representative of disk diffusion in vitro susceptibility of enrofloxacin for bacterial organisms from the middle-ear tissue of dogs with end-stage otitis externa.
Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Dog Diseases; Dogs; Enrofloxacin; Female; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Male; Microbial Sensitivity Tests; Otitis Externa; Predictive Value of Tests; Severity of Illness Index | 2006 |
4 other study(ies) available for enrofloxacin and Otitis Externa
| Article | Year |
|---|---|
The stability and in vitro antibacterial efficacy of enrofloxacin and gentamicin solutions against Staphylococcus pseudintermedius over 28 days.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Dexamethasone; Dog Diseases; Dogs; Enrofloxacin; Gentamicins; Microbial Sensitivity Tests; Otitis Externa; Saline Solution | 2023 |
Biofilm production by pathogens associated with canine otitis externa, and the antibiofilm activity of ionophores and antimicrobial adjuvants.
Topics: Acetylcysteine; Animals; Anti-Infective Agents; Bacteria; Biofilms; Dog Diseases; Dogs; Edetic Acid; Enrofloxacin; Ionophores; Microbial Sensitivity Tests; Monensin; Otitis Externa; Pyrans | 2019 |
Development of resistant bacteria isolated from dogs with otitis externa or urinary tract infections after exposure to enrofloxacin in vitro.
Topics: Animals; Anti-Infective Agents; Dog Diseases; Dogs; Drug Resistance, Bacterial; Enrofloxacin; Enterococcus; Escherichia coli; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Klebsiella; Microbial Sensitivity Tests; Otitis Externa; Proteus mirabilis; Pseudomonas aeruginosa; Quinolones; Staphylococcus; Urinary Tract Infections | 2002 |
What is your diagnosis? Mucocutaneous ulceration.
Topics: Administration, Topical; Animals; Anti-Infective Agents; Cephalexin; Cephalosporins; Diagnosis, Differential; Dog Diseases; Dogs; Enrofloxacin; Erythema Multiforme; Fluoroquinolones; Male; Otitis Externa; Quinolones | 1998 |